AI assistant
Sending…
ClearPoint Neuro, Inc. — Director's Dealing 2021
Aug 21, 2021
32641_dirs_2021-08-20_af24fbe8-8459-41d1-bd05-65d3673375dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2021-08-16
Reporting Person: Piferi Peter G. (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-16 | Common Stock | M | 8929 | $3.47 | Acquired | 68168 | Direct |
| 2021-08-16 | Common Stock | F | 1632 | $17.89 | Disposed | 66536 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-16 | Stock Options (right to buy) | $3.47 | M | 8929 | Disposed | 2029-08-15 | Common Stock (8929) | Direct |
More from ClearPoint Neuro, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19